Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 69 citing Marx: Thiazolidinediones reduce endothelial expression of receptors for advanced glycation.... (0.08 sec) 

Advanced glycation end products and the kidney

- physiology.org [PDF] 
JM Bohlender, S Franke, G Stein, G … - American Journal of …, 2005 - Am Physiological Soc
173 articles, 82 of which you can access free at: This article cites http://ajprenal.physiology.org
/cgi/content/full/289/4/F645#BIBL ... 11 other HighWire hosted articles, the first 5 are: This article
has been cited by ... [PDF] [Full Text] [Abstract] , April 1, 2008; 23 (4): 1166-1172. ...
Cited by 82 - Related articles - BL Direct - All 7 versions

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency …

- ahajournals.org
AC Calkin, JM Forbes, CM Smith, M Lassila, … - … , and vascular biology, 2005 - Am Heart Assoc
Methods and Results— Control and diabetic apolipoprotein E–deficient mice received rosiglitazone
or placebo. Diabetic mice demonstrated a 3-fold increase in plaque area, which was attenuated
by rosiglitazone. There was no significant difference in glucose, insulin, or cholesterol ...
Cited by 79 - Related articles - All 9 versions

Effect of rosiglitazone on endothelial function and inflammatory markers in patients …

- diabetesjournals.org
K Esposito, M Ciotola, D Carleo, B Schisano, F … - Diabetes Care, 2006 - Am Diabetes Assoc
RESULTS—Compared with 60 control subjects matched for age and sex, patients with the metabolic
syndrome had decreased endothelial function, raised concentrations of inflammatory
markers, and reduced insulin sensitivity. After 12 months, subjects with the metabolic ...
Cited by 71 - Related articles - BL Direct - All 5 versions

Commonality in chronic inflammatory diseases: periodontitis, diabetes, and …

- smajournalonline.org
JH Southerland, GW Taylor, K Moss, JD Beck, … - PERIODONTOLOGY …, 2006 - pt.wkhealth.com
Diabetes, coronary artery disease, and adult periodontitis are common chronic diseases observed
in a significant proportion of the adult US population. Diabetes is a metabolic disease that, due
to disturbances in insulin production, leads to abnormal fat, sugar, and protein ...
Cited by 46 - Related articles - BL Direct - All 6 versions

Role of the PPAR family of nuclear receptors in the regulation of metabolic and …


G Chinetti-Gbaguidi, JC Fruchart, B Staels - Current Opinion in Pharmacology, 2005 - Elsevier
Several conditions and risk factors predispose to cardiovascular disease, including visceral
obesity, type 2 diabetes, insulin resistance, hypertension and dyslipidemia, and are collectively
called the metabolic syndrome. Different pharmacological approaches are under ...
Cited by 40 - Related articles - All 2 versions

Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in …

- ahajournals.org [PDF] 
C Cuccurullo, A Iezzi, ML Fazia, D De Cesare, … - … , and vascular biology, 2006 - Am Heart Assoc
Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Suppression of Rage as a Basis of Simvastatin-Dependent
Cited by 40 - Related articles - All 9 versions

Diabetic nephropathy: where hemodynamics meets metabolism

- biovita.fi [PDF] 
JM Forbes, K Fukami, ME Cooper… - Experimental and Clinical …, 2007 - thieme-connect.com
Diabetic nephropathy (DN), the most common cause of end stage renal disease in developed
nations, is thought to result from interactions between metabolic and haemodynamic factors.
Specific metabolically driven, glucose dependent pathways are activated within diabetic ...
Cited by 36 - Related articles - BL Direct - All 7 versions

Telmisartan inhibits AGE-induced C-reactive protein production through …


T Yoshida, S Yamagishi, K Nakamura, T Matsui, T … - Diabetologia, 2006 - Springer
Page 1. SHORT COMMUNICATION Telmisartan inhibits AGE-induced C-reactive protein
production through downregulation of the receptor for AGE via peroxisome proliferator-activated
receptor-gamma activation T. Yoshida & S. Yamagishi & K. Nakamura & T. Matsui & ...
Cited by 33 - Related articles - BL Direct - All 5 versions

Peroxisome Proliferator-Activated Receptor {gamma} Down-Regulates Receptor …

- aspetjournals.org
K Wang, Z Zhou, M Zhang, L Fan, F Forudi, X Zhou, … - Journal of Pharmacology …, 2006 - ASPET
Diabetes is associated with an increase in circulating advanced glycosylation end products
(AGEs) and the increased expression of the receptor for AGEs (RAGE). Inhibition of AGE/RAGE
binding through the administration of soluble RAGE (sRAGE) has been shown to ...
Cited by 33 - Related articles - BL Direct - All 6 versions

Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in …


JL Figarola, N Shanmugam, R Natarajan, S Rahbar - Diabetes, 2007 - Am Diabetes Assoc
Ligation of advanced glycation end products (AGEs) with their receptor (RAGE) plays an important
role in the development of various diabetes complications, including atherosclerosis. Monocyte
activation, adhesion, and migration are key events in the pathogenesis of atherosclerosis. ...
Cited by 29 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google